IL6, one of the mediators of the immune/inflammation response and inducers of EMT, can increase cancer-associated stemness and MMP activity and M2 macrophage polarization via the MCT-1/miR-34a/IL-6/IL-6R signaling pathway [13]. This evidence concerns the gene IL6R and cancer.